Chugai Pharmaceutical Co., Ltd. (CHGCY)
Chugai Pharmaceutical Co., Ltd. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Tokyo, SH, JP. The stock last traded at $22.62, up 1.85% on the session, giving a market capitalisation of $74.45B. On trailing twelve-month figures it carries a trailing P/E of 25.08, a net margin of 35.1%. Its beta of 0.58 implies it has historically moved less than the broad market.
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
Chugai Pharmaceutical Co., Ltd. is most often compared with the following Healthcare names: